You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Moderna簽署協議為世界上最貧窮的人提供新的變體適應性COVID-19疫苗
格隆匯 10-18 15:44
格隆匯10月18日丨據市場消息,Moderna已同意向旨在為世界上最貧窮的人提供疫苗的全球計劃提供其新的變體適應性COVID-19疫苗。Moderna和疫苗聯盟GAVI將取消現有的基於原始冠狀病毒毒株的疫苗供應協議。而從2023年起,Moderna將以最低價格供應至多1億劑新型可適應變異毒株疫苗。全球疫苗和免疫聯盟與世界衞生組織和其他全球機構一起領導全球獲取疫苗倡議。該計劃已向146個國家提供了17.9億劑新冠肺炎疫苗,其中包括近1.86億劑Moderna原疫苗。起初,由於富裕國家搶購有限的疫苗供應,該計劃很難獲得疫苗,但今年原始疫苗出現了過剩,促使各方展開談判,試圖更好地協調供需。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account